药物基因组测试对患有重度抑郁症患者初始缓解和反应率的持续益处
Daniel Hain1, Andria L Del Tredici1, Ryan B Griggs1
1Myriad Genetics, Salt Lake City, UT, United States.
Frontiers in pharmacology
|November 17, 2025
概括
药基因组测试改善了主要抑郁症 (MDD) 患者的缓解和反应率. 这种益处持续了六个月,表明引导治疗的持续效果.
科学领域:
- 精神病学是一个精神病学.
- 药物基因组学 药物基因组学
- 临床医学 临床医学
背景情况:
- 大型抑郁症 (MDD) 治疗通常涉及到漫长的试错药物选择.
- 药基因组测试可以提高MDD患者的缓解和反应率.
- 关于药物基因组指导治疗MDD的长期影响的数据有限.
研究的目的:
- 为了确定药物基因组指导的治疗是否会随着时间的推移增加MDD患者的缓解和反应率.
- 评估药物遗传学指导的治疗益处的持续性.
主要方法:
- 对PRIME Care随机临床试验的预规定的特此后分析.
- 药物基因组指导治疗与抑郁症退伍军人的通常护理进行了比较.
- 多变量考克斯比例危险模型使用PHQ-9尺度分析了缓解率和反应率.
主要成果:
- 与常规护理相比,药物基因组指导治疗与更高的缓解率 (HR 1.27) 和反应率 (HR 1.21) 相关.
- 从1944名参与者中分析了1764名退伍军人的数据.
- 没有证据表明治疗效益在24周的研究期间发生了变化.
结论:
- 药物基因组指导的治疗加速了MDD患者的初始缓解和反应.
- 药物基因组指导的观察到的好处持续至少六个月.
- 药物基因组测试对MDD治疗疗效的积极影响随着时间的推移而持续.
相关概念视频
Psychosis: Goals of Pharmacotherapy
453
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
453
Measurement of Bioavailability: Pharmacodynamic Methods
225
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
225
Factors Affecting Drug Response: Overview
2.9K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.9K
Therapeutic Drug Monitoring: Affecting Factors
189
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
189
Therapeutic Drug Monitoring: Overview and Classification
282
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
282
Antidepressant Drugs: MAOIs and Other Agents
784
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
784


